@Psych_Fin

Helping investors discover, understand, and stay up-to-date on opportunities within the Psychedelic industry. Inquiries: [email protected]

 Canada
psychedelicfinance.com
Joined November 2019
  • Tweets4.3K
  • Following153
  • Followers20.8K
45Media
Welcome to Psychedelic Finance. We exist to help bridge the gap between the exciting world of psychedelic medicine and the companies being built around it. If you'd like to see our more detailed research on the industry, you can join the community here: psychedelicfinance.com/

Psychedelic Finance

Psychedelic Finance is the source for the latest financial news, company features, and interviews with the top minds and companies in psychedelics.

psychedelicfinance.com
31
36
8
134
$PBM
The Tape
@TheTape_TNMOct 21
Breaking: $PBM has completed an additional $2.6 million cash investment in psychedelic ingredient developer PsyLabs, raising its stake from approximately 41.13% to 43.37%.
1
1,575
$CMND
The Tape
@TheTape_TNMOct 7
Breaking: $CMND submits FDA recommendations seeking faster approval pathways and potential at-home use of psychedelic-derived treatments that avoid hallucinations.
4
618
$PBM
The Tape
@TheTape_TNMSep 28
Breaking: $PBM’s Texas unit signs a binding term sheet for exclusive U.S. rights to develop and distribute PsyLabs’ ibogaine, with up to $1.3 million in milestones; a final deal is due by November 30.
1
3
1,470
$PBM
The Tape
@TheTape_TNMSep 23
Breaking: $PBM agrees to invest up to $5 million in PsyLabs, including $2.4 million committed, plus a roughly $9 million share swap to support a potential Texas trial of ibogaine for opioid use disorder.
2
714
$ENVB
The Tape
@TheTape_TNMSep 15
Breaking: $ENVB receives its third U.S. patent allowance for EVM401, covering non-hallucinogenic mescaline-derived drug candidates for potential PTSD and other mental health treatments.
1
763
$PBM
The Tape
@TheTape_TNMSep 14
Breaking: $PBM forms Texas Ibogaine Research Corp. to coordinate U.S. drug supply, regulatory work and potential clinical development.
3
839
$DFTX
The Tape
@TheTape_TNMSep 8
Breaking: $DFTX receives FDA Breakthrough Therapy designation for DT120 in major depression after a positive Phase 3 trial showed durable improvement through Week 12.
12
881
Psychedelic Finance retweeted
The Tape
@TheTape_TNMSep 8
Breaking: $DFTX receives FDA Breakthrough Therapy designation for DT120 in major depression after a positive Phase 3 trial showed durable improvement through Week 12.
1
1
7
1,101
Psychedelic Finance retweeted
The Tape
@TheTape_TNMAug 14
Breaking: $HELP completes enrollment in its Phase 3 HLP003 depression trial with topline data expected in Q4, while Q1 net loss widens to $47.8 million and cash stands at $166.4 million.
2
9
762
Psychedelic Finance retweeted
The New Money
@thenewmoneyAug 6
Breaking: Compass Pathways has partnered with the U.S. Department of Veterans Affairs for a new psilocybin study. $CMPS $ATAI $LLY thenew.money/article/compass…

Compass Pathways Launches New Psilocybin Study With U.S. Department of Veterans Affairs | The New...

Compass Pathways (NASDAQ: CMPS) has partnered with the United States Department of Veterans Affairs on a multi-site randomized controlled clinical trial.

thenew.money
3
6
781
Psychedelic Finance retweeted
The Tape
@TheTape_TNMAug 6
Breaking: $CMPS partners with the U.S. Department of Veterans Affairs on a five-site trial of COMP360 psilocybin for veterans with treatment-resistant depression, including those with PTSD.
2
4
13
829
Psychedelic Finance retweeted
The Tape
@TheTape_TNMAug 4
Breaking: Shares of psychedelic drug discovery company $HELP have surged +50% over the past month.
2
3
11
789
Psychedelic Finance retweeted
The Tape
@TheTape_TNMJul 21
Breaking: $HELP completes 223-patient Phase 3 enrollment for depression drug HLP003 ahead of schedule, with topline data due Q4 2026.
1
2
12
567
Psychedelic Finance retweeted
The New Money
@thenewmoneyJul 16
Eli Lilly has entered into a new deal to acquire AtaiBeckley for up to $3.5 billion in the drugmaker’s first ever psychedelic drug discovery acquisition. $ATAI $LLY @C_Angermayer thenew.money/article/eli-lil…

Eli Lilly Is Acquiring AtaiBeckley For Psychedelic Drug Development | The New Money

Eli Lilly (NYSE: LLY) has entered into a new deal to acquire AtaiBeckley (NASDAQ: ATAI) for up to $3.5 billion.

thenew.money
5
8
947
Psychedelic Finance retweeted
The New Money
@thenewmoneyJun 26
Definium Therapeutics has just completed a massive new capital raise. And they are aiming to use it to bring their most advanced psychedelic derived drug into commercialization. $DFTX thenew.money/article/definiu…

Definium Therapeutics Raises Mega Funding Round To Advance LSD Drug | The New Money

Definium Therapeutics (NASDAQ: DFTX) has successfully raised $805 million in a new equity financing round at a price of $34.00 per share.

thenew.money
1
9
796
Psychedelic Finance retweeted
The Tape
@TheTape_TNMJun 22
Breaking: $CMND completes treatment of all 24 participants across four cohorts in Part A of its FDA-regulated Phase I/II CMND-100 trial for alcohol use disorder and will review the data before advancing to the next stage.
1
6
529
Psychedelic Finance retweeted
The New Money
@thenewmoneyJun 11
A publicly traded company on the Nasdaq is shipping psilocybin to the United Kingdom. But, why? $OPTH thenew.money/article/optimi-…

Optimi Health Is Shipping Psilocybin To The UK | The New Money

Optimi Health (NASDAQ: OPTH) has successfully exported naturally derived psilocybin to the United Kingdom to support a Phase II clinical trial.

thenew.money
1
2
5
380
Psychedelic Finance retweeted
The Tape
@TheTape_TNMJun 10
Breaking: $OPTH completes its first export of naturally derived psilocybin to the United Kingdom, supplying biomass and finished 5mg capsules for a planned Phase 2 clinical trial under Health Canada and UK Home Office authorization.
1
1
4
328
Psychedelic Finance retweeted
The Tape
@TheTape_TNMJun 1
Breaking: $TELIF signs an agreement to deploy its third Self-Driving Lab platform of fiscal 2026 for a major global pharmaceutical company in Europe.
1
5
418
Psychedelic Finance retweeted
The Tape
@TheTape_TNMMay 28
Breaking: $ATAI launches a Patient Impact Grant Program awarding three $20,000 grants to mental health non-profits focused on community support, education, stigma reduction and independent research.
3
10
428
Load more